- Coca-Cola Icecek reported a net income of 14.8 billion liras for the fiscal year, representing a 50% decrease compared to the previous year.
- Sales for the year amounted to 137.7 billion liras, which is a 5.6% decrease from the previous year.
- Pre-tax income stood at 19.9 billion liras for the year.
- The company anticipates mid-single-digit growth in sales volume on a consolidated basis for the year 2025.
- Projected mid-single-digit growth in net sales revenue per unit case with a stable EBIT margin for 2025.
- Investment community sentiment is predominantly positive, with 17 buy recommendations, 2 holds, and no sell ratings.
A look at Coca-Cola Icecek Smart Scores
| Factor | Score | Magnitude |
|---|---|---|
| Value | 3 | |
| Dividend | 3 | |
| Growth | 5 | |
| Resilience | 3 | |
| Momentum | 3 | |
| OVERALL SMART SCORE | 3.4 |
Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma
When looking at the long-term outlook for Coca-Cola Icecek, the company is positioned well for growth according to the Smartkarma Smart Scores. With a high score of 5 in Growth, Coca-Cola Icecek is expected to continue expanding its market presence and sales. This indicates that the company has strong potential for future development and increasing its market share in the beverage industry.
Additionally, Coca-Cola Icecek scores moderately well in Value, Dividend, Resilience, and Momentum, with scores of 3 across these factors. This suggests that while the company may not be undervalued based on its current financials, it still offers a solid investment opportunity with stable dividends, resilience in the face of challenges, and positive momentum in its operations. Overall, Coca-Cola Icecek‘s outlook appears positive for the long term, especially considering its focus on bottling and distributing a range of soft drinks and beverages.
Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.
💡 Before it’s here, it’s on Smartkarma
Sign Up for Free
The Smartkarma Preview Pass is your entry to the Independent Investment Research Network
- ✓ Unlimited Research Summaries
- ✓ Personalised Alerts
- ✓ Custom Watchlists
- ✓ Company Analytics and News
- ✓ Events & Webinars
